Crossmark Global Holdings, Inc. Sanofi Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Sanofi stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 44,289 shares of SNY stock, worth $2.14 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

44,289

Previous 35,795 23.73%

Holding current value

$2.14 Million

Previous $1.74 Million 46.92%

% of portfolio

0.05%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$48.54 - $58.53 $412,298 - $497,153	8,494 Added 23.73%	44,289 $2.55 Million
Q2 2024 Jul 29, 2024	BUY	$45.39 - $50.36 $30,138 - $33,439	664 Added 1.89%	35,795 $1.74 Million
Q1 2024 May 13, 2024	SELL	$45.75 - $52.48 $52,292 - $59,984	-1,143 Reduced 3.15%	35,131 $1.71 Million
Q4 2023 Feb 13, 2024	BUY	$43.13 - $54.79 $37,479 - $47,612	869 Added 2.45%	36,274 $1.8 Million
Q3 2023 Nov 08, 2023	SELL	$50.95 - $55.2 $13,450 - $14,572	-264 Reduced 0.74%	35,405 $1.93 Million
Q2 2023 Jul 31, 2023	BUY	$50.45 - $57.18 $51,004 - $57,808	1,011 Added 2.92%	35,669 $1.87 Million
Q1 2023 May 12, 2023	SELL	$45.86 - $54.45 $22,150 - $26,299	-483 Reduced 1.37%	34,658 $1.89 Million
Q4 2022 Jan 19, 2023	BUY	$38.86 - $48.55 $33,186 - $41,461	854 Added 2.49%	35,141 $1.7 Million
Q3 2022 Nov 01, 2022	BUY	$37.22 - $100.5 $132,391 - $357,478	3,557 Added 11.58%	34,287 $1.3 Million
Q2 2022 Jul 29, 2022	SELL	$48.99 - $57.46 $27,924 - $32,752	-570 Reduced 1.82%	30,730 $1.54 Million
Q1 2022 May 11, 2022	BUY	$48.48 - $53.65 $105,686 - $116,957	2,180 Added 7.49%	31,300 $1.61 Million
Q4 2021 Jan 10, 2022	SELL	$47.07 - $52.35 $30,595 - $34,027	-650 Reduced 2.18%	29,120 $1.46 Million
Q3 2021 Oct 21, 2021	BUY	$47.89 - $53.12 $667,586 - $740,492	13,940 Added 88.06%	29,770 $1.44 Million
Q3 2021 Oct 13, 2021	SELL	$47.89 - $53.12 $566,538 - $628,409	-11,830 Reduced 42.77%	15,830 $682,000
Q2 2021 Jul 21, 2021	BUY	$49.36 - $54.25 $2,468 - $2,712	50 Added 0.18%	27,660 $1.46 Million
Q1 2021 Apr 15, 2021	SELL	$45.46 - $50.51 $473,875 - $526,516	-10,424 Reduced 27.41%	27,610 $1.37 Million
Q4 2020 Jan 14, 2021	SELL	$45.3 - $51.62 $27,723 - $31,591	-612 Reduced 1.58%	38,034 $1.85 Million
Q3 2020 Oct 08, 2020	BUY	$49.47 - $53.77 $5,441 - $5,914	110 Added 0.29%	38,646 $1.94 Million
Q2 2020 Aug 14, 2020	SELL	$42.91 - $52.5 $5,492 - $6,720	-128 Reduced 0.33%	38,536 $1.97 Million
Q1 2020 Apr 28, 2020	BUY	$38.02 - $51.66 $74,899 - $101,770	1,970 Added 5.37%	38,664 $1.69 Million
Q4 2019 Feb 06, 2020	BUY	$44.25 - $50.86 $97,792 - $112,400	2,210 Added 6.41%	36,694 $1.84 Million
Q3 2019 Oct 09, 2019	SELL	$40.34 - $46.64 $1.13 Million - $1.31 Million	-27,990 Reduced 44.8%	34,484 $1.6 Million
Q2 2019 Jul 09, 2019	BUY	$40.43 - $44.3 $39,621 - $43,414	980 Added 1.59%	62,474 $2.7 Million
Q1 2019 May 02, 2019	BUY	$40.83 - $45.43 $96,767 - $107,669	2,370 Added 4.01%	61,494 $2.72 Million
Q4 2018 Jan 31, 2019	SELL	$41.48 - $45.59 $10,370 - $11,397	-250 Reduced 0.42%	59,124 $2.57 Million
Q3 2018 Nov 08, 2018	BUY	$40.0 - $44.84 $1.03 Million - $1.15 Million	25,630 Added 75.95%	59,374 $2.65 Million
Q2 2018 Jul 31, 2018	SELL	$37.63 - $41.22 $1.35 Million - $1.48 Million	-35,790 Reduced 51.47%	33,744 $1.35 Million
Q1 2018 Apr 16, 2018	SELL	$38.98 - $45.76 $788,877 - $926,090	-20,238 Reduced 22.54%	69,534 $2.79 Million
Q4 2017 Feb 05, 2018	SELL	$42.86 - $50.61 $143,152 - $169,037	-3,340 Reduced 3.59%	89,772 $3.86 Million
Q3 2016 Oct 25, 2017	BUY	N/A	93,112	93,112 $4.64 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Sanofi Transaction History